Investigating the Efficacy of Cognitive-Behavioral Therapy and Hope Therapy on Quality of Life, Life Expectancy and Resiliency in Patients with Thalassemia

Not Applicable

• Conditions: Patients with Thalassemia.; Thalassaemia: Beta major

• Registration Number: IRCT20190227042861N1
• Lead Sponsor: Boushehr University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 March 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with thalassemia diagnosis who were taking regular treatment
Had relative mental, cognitive and physical health
Had not any record of hospitalization in that past one month
Willing to participate
Sufficient literacy

Exclusion Criteria

Patients with an acute and new diagnosis
Patients who referred to the center temporarily or occasionally
Those with significant cognitive and psychological complications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: beginning of the study and one month later. Method of measurement: World Health Organization Quality of Life Questionnaire.;Life expectancy. Timepoint: beginning of the study and one month later. Method of measurement: Life Expectancy Questionnaire by Schneider.;Resiliency. Timepoint: beginning of the study and one month later. Method of measurement: Connor–Davidson Resilience Scale.;Anxiety. Timepoint: beginning of the study and one month later. Method of measurement: Beck Anxiety Inventory.;Depression. Timepoint: beginning of the study and one month later. Method of measurement: Beck Depression Inventory.